ANTX vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

ANTX

38.7
AI Score
VS
ANTX Wins

JBIO

36.0
AI Score

Investment Advisor Scores

ANTX

39score
Recommendation
SELL

JBIO

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ANTX JBIO Winner
Net Income -26.20M -96.13M ANTX
Operating Income -28.13M -102.36M ANTX
ROE -34.7% -21.9% JBIO
ROA -32.0% -20.4% JBIO
Total Assets 81.95M 472.11M JBIO
Cash 20.21M 107.25M JBIO
Current Ratio 10.48 14.93 JBIO

Relative Price Performance (Last 90 Days)

ANTX 1M: +23.9% · 3M: -25.4% JBIO 1M: +23.2% · 3M: -30.5%

Current Technical Phase

ANTX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.1 · Price: $4.46

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 62.8 · Price: $16.54

Fundamentals Snapshot

Metric ANTX JBIO
Market Cap — —
Forward P/E -5.8 -6.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -0.91 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ANTX is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.